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In recent years, our understanding of the role of natural killer (NK) cells in the response to
viral infection has grown rapidly. Not only do we realize viruses have many immune-evasion
strategies to escape NK cell responses, but that stimulation of NK cell subsets during an
antiviral response occurs through receptors seemingly geared directly at viral products and
that NK cells can provide a memory response to viral pathogens. Tremendous knowledge
has been gained in this area through the study of herpes viruses, but appreciation for
the signiﬁcance of NK cells in the response to other types of viral infections is growing.
The function of NK cells in defense against poxviruses has emerged over several decades
beginning with the early seminal studies showing the role of NK cells and the NK gene
complex in susceptibility ofmouse strains to ectromelia, a poxvirus pathogen ofmice. More
recently, greater understanding has emerged of the molecular details of the response.
Given that human diseases caused by poxviruses can be as lethal as smallpox or as benign
as Molluscum contagiosum, and that vaccinia virus, the prototypic member of the pox
family, persists as a mainstay of vaccine design and has potential as an oncolytic virus
for tumor therapy, further research in this area remains important. This review focuses
on recent advances in understanding the role of NK cells in the immune response to
poxviruses, the receptors involved in activation of NK cells during poxvirus infection, and
the viral evasion strategies poxviruses employ to avoid the NK response.
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INTRODUCTION
Natural killer (NK) cells are generally part of theﬁrst line of defense
to viral infection, but their relative importance to the immune
response can vary depending on the virus (Bukowski et al., 1983;
Lanier, 2008). NK cells can limit viral replication directly by lysing
virus-infected cells, and are also stimulated during a viral infec-
tion through cytokines to produce antiviral cytokines such as
interferon-gamma (IFN-γ). NK cell responses are rapid and rely
on germ-line encoded receptors systems to detect infection, lead-
ing to their categorization as innate immune cells. However, NK
cells are lymphocytes by lineage and do share features with the
adaptive immune response. Importantly, as ﬁrst documented in
micewithmurine cytomegalovirus, cognate stimulation through a
“pathogen-speciﬁc” receptor (Ly49H) expressed by a subset of NK
cells, leads to speciﬁc proliferation and maintenance of popula-
tions of NK cells with heightened function in a formnow generally
accepted as NK cell memory (Arase et al., 2002; Sun et al., 2009).
While the role of NK cells during herpes virus infection has been
well established and dissected, poxviruses also present an inter-
esting family of viruses to consider in the context of the NK cell
response.
BASIC BACKGROUND ON POXVIRUSES
Suggestive of their ancient origin, poxviruses infect a wide variety
of forms of life with families of poxviruses that infect invertebrates,
reptiles, birds, and mammals. Poxviruses that infect mammals
are further divided into a number of subgroups including the
well-studied orthopox genus. The orthopox genus includes many
different viruses that are both medically relevant and well studied
as models for pathogenesis such as: ectromelia virus, a natural
pathogen of mice; variola virus, the causative agent of smallpox;
cowpox, a virus that is maintained in rodents but able to infect a
broad range of mammals; and vaccinia virus, a virus likely derived
froman extinct equine virus.Vaccinia viruswas used as the vaccine
successfully to eradicate variola virus and remains under investi-
gation as a general vaccine vector as well as an oncolytic virus.
Orthopox viruses cause a wide range of diseases and even a single
type of virus will have a range of clinical course in different indi-
viduals. For example, while variola virus caused only a mild and
localized disease in some individuals, many succumbed to severe
disease with very high mortality rates especially for some strains
of the virus (reviewed in Bray and Buller, 2004). A much lesser
known poxvirus that infects only humans is Molluscum contagio-
sum that resides in a genus of its own and for themost part it causes
only a very localized and mild infection. The severity of disease
by poxviruses is correlated with host control of viral replication
within the incubation phase (e.g., 10–14 days for variola virus;
Bray and Buller, 2004). Therefore, while many variables may play
into how a particular individual responds to infection, including
the dose and route of the inoculum, genetic differences related to
the NK cell responses may inﬂuence the response to a poxvirus
infection in many species including humans.
How the host cell detects the virus within itself and the effects
of the virus of cellular proteins may impact the types of molecules
cells express or loose that relate to NK cell recognition of an
infected cell and the types of cytokines produced that can activate
NK cells. Therefore, there are several features of poxviruses that are
worth highlighting here to appreciate how NK cells may combat
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these viruses, particularly in contrast to the situation with her-
pes viruses. Similar to herpes viruses, poxviruses prevent host
protein expression mainly through destruction of cellular mRNA
such that some cell surface proteins must diminish over the course
of infection through their natural turnover rates. In contrast to
herpes viruses, poxviruses generally do not establish persistent or
latent infections and therefore may not require the same type of
evasion of T cells and only a few poxviruses are known to actively
targetmajor histocompatibility complex class I (MHC-I) proteins.
However, poxviruses do devote a considerable proportion (∼50%)
of the their rather large genomes (∼200 genes) manipulating the
hosts’ innate and adaptive immune defenses (reviewed in Vermi
et al., 2011). The need to encode so many immunomodulatory
genes has been suggested to stem from the virus’ relative inabil-
ity to rapidly mutate to evade the adaptive immune response.
Of note, cowpox possesses the most genes predicted to modu-
late the immune system and is thought to be closest to the most
ancient orthopoxvirus. The remainder of this review examines
the NK cell response to poxvirus infection, current knowledge
regarding NK cell recognition of cells infected by poxviruses and
various immune-evasion strategies encoded by poxviruses that
may inﬂuence the NK response.
THE IN VIVO MOUSE NK CELL RESPONSE TO POXVIRUS
INFECTION
The majority of what we know about the role of the NK cell
response to poxviruses has been drawn from vaccinia virus and
ectromelia virus infection of mice which have many similarities
and some differences. Many years ago it was recognized that a
few inbred strains of mice such as C57BL/6 and AKR/J mice
exhibit much greater resistance to ectromelia virus than most
inbred strains such as BALB/c and DBA, for which infection is
lethal (Briody et al., 1956). NK cells are important to the response
to both ectromelia and vaccinia virus as depletion of NK cells
in C57BL/6 mice leads to severe infection with ectromelia, and
also causes increases in titers of vaccinia virus (Bukowski et al.,
1983; Jacoby et al., 1989; Delano and Brownstein, 1995; Fang et al.,
2008). At least one immune-evasion tactic of both these viruses is
through interfering with the NK cell response using proteins that
antagonize IL-18 function (Born et al., 2000; Reading and Smith,
2003). The ectromelia protein SPI-2 and the vaccinia virus protein
N1 also act to limit NK cell responses although the mechanism of
action is not clear for either of these proteins (Jacobs et al., 2008;
Melo-Silva et al., 2011). It is important to mention here that while
NK cells are essential for resistance to ectromelia virus, they are
not sufﬁcient, and recovery from infection requires antibody as
well as CD4 and CD8 T cell responses (Karupiah et al., 1993; Fang
and Sigal, 2005; Parker et al., 2007).
Ectromelia infection occurs naturally through abrasions of the
footpad and is spreads to organs such as spleen, liver, lung, and
even thymus, likely via the lymphatic system. Susceptible mice
develop classic pox lesions on the skin and succumb to the infec-
tion within days to weeks following infection. When mice are
experimentally inoculated in the footpad with a low dose (50 pfu),
NK cells are found in increased numbers in the popliteal lymph
node 2 days after infection, while the peak in spleen and liver
occurs at 6 days (Parker et al., 2007). NK cells are not actively
proliferating at these distal sites until day 4–6 and are found sur-
rounding foci of viral production in the liver. Peak NK activity
3–6 days post-infection has been shown in the spleen for several
strains including susceptible strains such as BALB/c (Chaudhri
et al., 2004). Depletion studies have shown the NK response is
required for resistance during the ﬁrst few days, and by day 5,
their depletion does not have a major impact on recovery, likely
because the adaptive immune response has taken over (Dennehy
et al., 2010). The early viral control appears to be mediated by NK
cells recruited to the draining lymph node and perhaps the site of
infection in the dermis without proliferation of the NK cells. It is
not clear whether the proliferation of the NK cells is required for
control in other organs, formation of memory or serves a home-
ostatic function to preserve NK cell numbers. Although cowpox
is actually endemic in wild rodents, a recent report shows that
depletion of NK cells in C57BL/6 mice does not affect mortality
following footpad inoculation (Pak-Wittel et al., 2013). However,
without NK cells replication of the virus in the draining lymph
node does increase substantially and the NK cells are recruited to
the draining node through a CXCR3 and IFN-γ-dependent pro-
cess. As will be discussed in detail below, the reason that NK cells
do not appear to matter in the response to cowpox in mice may
be due to immune-evasion proteins that limit the efﬁcacy of the
NK cells.
In contrast to the situation with ectromelia virus, most strains
of mice are generally resistant to vaccinia virus infection suffering
few symptoms. However, C57BL/6 may control viral replication
in the spleen and liver better than C3H mice (Bukowski et al.,
1983). Experimental infection of mice is most often done by
intraperitoneal injection with relatively high doses of this virus
(e.g., 5 × 106 pfu). Older studies show that activated NK cells
accumulate in the peritoneal cavity in response chemokines fol-
lowing an intraperitoneal inoculation with vaccinia virus (Natuk
and Welsh, 1987; Prlic et al., 2005). Maximal proliferation of NK
cells occurs 2 days post-infection in both the spleen and peritoneal
cavity, with greater proliferation occurring in the spleen (Prlic
et al., 2005). The earlier proliferation in the case of vaccinia virus
compared with ectromelia may be a consequence of the time it
takes ectromelia to disseminate from the skin to the internal organs
where the NK cells will proliferate, but the dose of virus as well as
different properties inherent to the two virusesmay also impact the
NK response. Recently, it was shown that the response to vaccinia
virus in mice requires Toll-like receptor (TLR2) signaling directly
on the NK cells (Martinez et al., 2010). This is surprising because
this study was also the ﬁrst report of TLR2 on mouse NK cells.
Several studies published this past year have illustrated the role of
macrophages and related cells in regulating the NK cell response
to vaccinia virus following infection IP and through the footpad.
Following footpad injection of the highly attenuated modiﬁed
vaccinia Ankara (MVA) strain, NK cells accumulate in the drain-
ing lymph nodes and become activated in a process dependent
on CXCR3 and macrophages and type I interferon (Garcia et al.,
2012). This virus is captured by subcapsular macrophages in the
draining node that prevents its spread to the spleen and these cells
are likely important to provide IL-18 to activate NK cells (Kasten-
muller et al., 2012). In addition, myeloid-derived suppressor cells
are able to regulate NK responses to vaccinia virus and prevent
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immunopathology through heightened IFN-γ responses as deple-
tion of these cells using anti-Gr1 leads to enhanced NK responses,
decreased viral replication but increased mortality following IP
injection of wildtype vaccinia virus (Fortin et al., 2012). These
authors also showed that granulocytic myeloid-derived suppres-
sor cells could suppress NK activation by vaccinia virus-infected
dendritic cells in vitro.
A curious feature of the resistance to ectromelia virus is that it
wanes quite dramatically with age (Fang et al., 2010). Sigal and col-
leagues showed that agedmice do notmake the necessary cytotoxic
T cell responses, but it is the NK and not the T cells themselves
that are defective. NK cells from youngmice restore the protection
from lethal infection by limiting viral spread and the defective NK
response is correlated with an intrinsic defect in NK cell migra-
tion into draining lymph nodes (Fang et al., 2010). Aged mice
can make normal responses to attenuated ectromelia or vaccinia
virus suggesting that the action of NK cells at the site of infec-
tion early is what is key to containing the viral replication enough
to allow the adaptive response to overcome the infection. These
observations are puzzling as there is no obvious advantage for a
system to allow NK cell function to decline with age in general,
and one might expect increases in memory/primed NK cells of
conventionally housed animals. However, in evolutionary terms,
there might be an advantage to divert energy from general innate
immunity to sustainingmemory responses to common pathogens
in the environment an animal ages. Contrary to the effect of age
on resistance to ectromelia in C57BL/6 mice, the lesions produced
by vaccinia virus in BALB/c mice decrease with the age of the mice
(Tscharke et al., 2002). Recently it was shown that NK cells primed
to vaccinia virus are sufﬁcient to protect from a further challenge
in the absence of T and B cells (Gillard et al., 2011). The memory
NK cells that can mediate the protection are Thy1+ and reside
in the liver. The signiﬁcance of the Thy1 marker is unclear, but
their presence in the liver is similar to the original description of
hapten-primedmemoryNK cells residing in the liver able tomedi-
ate contact-dependent sensitivity reactions (reviewed in Paust and
von Andrian, 2011). Along these lines, it would be interesting to
determine if NK cells from young mice primed to ectromelia or
vaccinia virus can protect aging mice from ectromelia.
There are some interesting older observations that point to the
mechanism thatNKcells use toprevent lethal disease. Resistanceof
C57BL/6 mice is more pronounced for the natural route of infec-
tion through the footpad or for low doses injected intravenously,
while most strains show similar susceptibility to intranasal, intrac-
erebral, or intraperitoneal inoculation (Schell, 1960). Curiously,
intradermal inoculation of C57BL/6mice with vaccinia virus leads
to bigger lesions than in BALB/c or CBA mice (Tscharke et al.,
2002), but virus titers of the lesions were not performed in this
study and therefore the larger lesions could actually be due to
immunopathology of a more robust immune response. Perhaps
of some signiﬁcance, the effects on pathogenesis in mice of cer-
tain vaccinia virus proteins are only evident when the route of
infection is dermal, which may be due to interplay with NK cells
that seem to be key to containing virus in the draining lymph
nodes. Amongst these is A40R, a protein with some homology to
the proteins within the NK gene complex (NKC) such as NKG2A
(Tscharke et al., 2002) and the Bcl-2-like protein N1 in vaccinia
virus that limits NK cell responses in BALB/c mice (Jacobs et al.,
2008). In addition, the importance of NK cells to the response in
the skin has also been suggested through studies in amousemodel
of the deviated response to vaccinia virus in eczema patients. In
a mouse strain that is eczema-prone (NC/Nga mice), local IL-17
limits the NK response in the skin leading to the uncontrolled
viral replication and severe erosive lesions similar to the problems
associated with vaccinia virus vaccination in humans with eczema
(Kawakami et al., 2009).
ACTIVATING RECEPTORS INVOLVED IN NK CELL
RECOGNITION OF POXVIRUS-INFECTED CELLS
Precisely howNK cells become activated during poxvirus infection
is not entirely clear and likely has features that are dependent on
the virus in question. Given the key role of NK cells in limiting viral
replication early and that the control requires both IFN-γ and per-
forinmediatedmechanisms (Fang et al., 2008), several groups have
examined the interaction of NK cells with poxvirus-infected cells
to determine which activating and inhibitory receptors are impor-
tant for recognition and cytolysis of an infected target cell. These
studies have yielded varying results for vaccinia virus inmouse and
human and some apparent differences between ectromelia virus
and vaccinia virus. The known activating receptors on NK cells
include the natural cytotoxicity receptors (NCR), activating killer
cell immunoglobulin-like receptors (KIRs, human) and Ly49s
(mouse), NKp65 (human), NKRP1A (mouse), CD94/NKG2C
or E, NKG2D and the low afﬁnity Fc-receptor, CD16. To trig-
ger NK cell degranulation, these receptors all couple through
small signaling adaptor proteins such as Fcγ, CD3ζ, DAP12, and
DAP10. With primary human NK cell lines, the NCRs, NKp30,
NKp44, and NKp46, are involved in NK cell lysis of vaccinia virus-
infected primary ﬁbroblasts (Chisholm and Reyburn, 2006). In
this study, the infected ﬁbroblasts were lysed much more than
mock treated cells and this susceptibility required early gene
expression from the virus. In this same study, a role for NKG2D
in activation was not detected nor any evidence that NKG2D
ligands are upregulated as a consequence of infection. Recently,
Jarahian et al. (2011) showed that hemagglutinin from either vac-
cinia or ectromelia virus interact with the human NCRs NKp30
andNKp46. Vaccinia virus hemagglutinin protein is expressed late
in infection and counter-intuitively, deletion of the viral hemag-
glutinin protein from the virus in fact augmented lysis of infected
HeLa cells suggesting hemagglutinin interactions with one of the
NCRs may actually inhibit NK activation. This group did show
that the interaction with hemagglutinin limits NKp30 signaling
while weakly enhancing NKp46 signaling, but this was with an
NKp30/ζ chimeric receptor which may not behave in the mem-
brane precisely the same as the native receptor. Therefore, it
remains unclear what ligands are involved in triggering the NCRs
in this context and whether the ligands that induce NK cell acti-
vation may depend on the lineage of the infected cell. Taken
together, it appears thatmultiple receptor–ligand pairs govern how
a human NK cells are triggered by vaccinia virus-infected target
cell (Figure 1).
The only NCR expressed by inbred mice is NKp46, and there
are no studies directly addressing the role of NKp46 in mouse NK
activation by either vaccinia virus or ectromelia virus. However,
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FIGURE 1 | Human NK cell recognition of vaccinia virus-infected cells.The activating and inhibitory human receptors and ligands are shown for vaccinia virus
infection of human cells. The effect of infection on the ligands is indicated with an arrow for molecules that increase and a line to proteins that are reduced.
Sigal and colleagues did show that the signaling adaptor DAP12
andperhapsDAP10 are important for resistance to ectromelia sug-
gesting activating Ly49s and/orNKG2 receptors are involved (Fang
et al., 2008). While Ly49H was recently excluded as being required
for resistance to ectromelia (Fodil-Cornu et al., 2008), blockade
of NKG2D in vivo does increase viral dissemination. However,
the effect of NKG2D blockade is not as complete as removing
NK cells with depleting antibodies (Fang et al., 2008), which may
reﬂect efﬁciency of blockade or the role of other receptors. In
support of NKG2D’s involvement, lysis of target cells infected in
vitro is partially inhibited by NKG2D blockade. Infection of MEFs
also induces a modest increase in binding of soluble NKG2D and
expression of the ligands MULT1 and Rae-1 (Fang et al., 2008). At
this stage, it is not clearwhether the discrepancy in the induction of
NKG2D ligands betweenmouse andhuman is a difference between
how mouse and human cells respond to infection, differences in
the cell types studied, or a difference between ectromelia virus and
vaccinia virus. As will be discussed in more detail below, more
recent studies from the same group showed that CD94/NKG2E is
required for resistance to ectromelia virus in C57BL/6 mice (Fang
et al., 2011). CD94/NKG2E ﬁts with the requirement for DAP12 in
the response to ectromelia because CD94/NKG2E signals through
DAP12 (Fang et al., 2011). However, CD94 is not required for
the response to vaccinia virus indicating there are signiﬁcant dif-
ferences in how NK cells recognize vaccinia virus and ectromelia
virus-infected cells (Orr et al., 2010).
POXVIRUSES AND REGULATION OF MHC-I EXPRESSION AND
OTHER INHIBITORY LIGANDS
The current thinking in the ﬁeld contends that in order forNKcells
to respond to infected cells, the barrier of signals emanating from
inhibitory receptors has to be overcome. The inhibitory receptors
on NK cells that monitor classical MHC-I have shown extremely
dynamic and species-speciﬁc evolution that was surely shaped by
pathogens (Parham, 2008). This diversity includes expansion of
distinct receptors such as KIR in primates, cows, domestic cats,
dogs, and pigs and Ly49 in rodents and horses. NK cells can also
express CD94/NKG2A, an inhibitory receptor that recognizes the
non-classical MHC-I protein known as human leukocyte antigen
(HLA)-E in human and Qa-1 in mouse. For their own surface
expression, HLA-E and Qa-1 require peptides derived from the
signal sequences of classical MHC-I proteins, and therefore are
believed to serve as a general barometer of MHC-I protein syn-
thesis. It is generally accepted that viruses evolved mechanisms to
interfere with MHC-I expression to evade stimulating cytotoxic T
cells and then leading to NK cell mediated killing following loss of
Frontiers in Immunology | NK Cell Biology January 2013 | Volume 4 | Article 7 | 4
“ﬁmmu-04-00007” — 2013/1/25 — 13:15 — page 5 — #5
Burshtyn Pox and NK
cell surfaceMHC-I. The degree to which this mechanism of recog-
nition operates with poxviruses remains unclear and there are only
few examples of poxviruses with speciﬁc mechanisms known to
down-regulateMHC-I.Myxoma virus, a rabbit virus distinct from
the orthopox genus, reduces MHC-I expression in vitro on cells
of various species mediated by a “scrapin” with E3-ligase activity
(Guerin et al., 2002;Mansouri et al., 2003). It has not been formally
shown that modulation of MHC-I leads to NK cell activation in
rabbits, deletion of the scrapin does reduce virulence (Guerin et al.,
2002). Cowpox decreases both mouse and humanMHC-I protein
expressionon the cell surface using theproteinCPXV203, a protein
that sequesters MHC-I from the Golgi back to the endoplasmic
reticulum via a KDEL-like motif (Byun et al., 2007; Dasgupta
et al., 2007). Given that the reservoir for cowpox is most likely
rodents, one might expect it to then encode a decoy protein to
target murine MHC-I-speciﬁc inhibitory receptors on NK cells
to evade NK cell responses. Cowpox does encode an MHC-I-like
protein dubbed OMCP for “orthopoxvirus MHC-I-like protein”
that was identiﬁed by algorithm to predict proteins with anMHC-
I fold (Campbell et al., 2007). However, OMCP does not engage
MHC-I-speciﬁc inhibitory receptors on NK cells. Instead, OMCP
is a secreted protein that acts as a high afﬁnity NKG2D antagonist
for mouse and human NKG2D (Campbell et al., 2007). Therefore,
it appears poxviruses have evolved alternatemeans to evade activa-
tion of NK cells by antagonizing a major receptor for activation as
well as antagonizing cytokines involved in NK activation. Interest-
ingly, OMCP also binds to a murine receptor called FcR-like 5, an
inhibitory immunoglobulin superfamily protein that is restricted
to innate B cells and monocytes/macrophages (Campbell et al.,
2010). However, the functional signiﬁcance of this interaction is
unclear as is the normal physiologic function of FcR-like 5 pro-
tein. Swinepox (SPV003 and SPV148) and Yatapox viruses also
have secreted proteins that have loose homology to MHC-I α
chains (Seet et al., 2003) and although they bind to β2 microglob-
ulin, they are actually tumor necrosis factor (TNF) inhibitors
(Rahman et al., 2009).
It appears then that most orthopox viruses have lost speciﬁc
mechanisms for disrupting MHC-I expression, and monkeypox
is the only other virus with a counterpart to CPXV203. However,
a few studies have shown some downregulation of mouse and
human MHC-I during infection with vaccinia virus or ectromelia
virus. Experiments by one group have shown that humanNK cells
normally inhibited through CD94/NKGA where the subset of NK
cells that lysed vaccinia virus-infected cells suggest that HLA-E is
beingmodulated (Brooks et al., 2006). In these studies the amount
of classical MHC-I remained sufﬁcient to provide protection via
a KIR (Brooks et al., 2006) however, if HLA-E expression is being
compromised it implies production of classical MHC-I is reduced
thereby limiting the supply of peptides to stabilize HLA-E. In con-
trast, we observed changes in MHC-I HLA-C that were sufﬁcient
to reduce KIR-mediated inhibition by NK clones (Kirwan et al.,
2006). It is likely that the dose of virus and length of infection, as
well as the stability of the MHC-I molecules in question inﬂuence
the degree to which MHC-I loss allows KIR-mediated inhibition
to be overcome. It is worth noting though that for humanMHC-I,
HLA-C is both themajor subtype ofMHC-ImonitoredbyKIR and
is characterized by unstable mRNA and relatively low protein. The
question still remains of whether MHC-I modulation has a role
in any poxvirus infection in vivo and the kinetics of the decrease
in MHC-I suggest that for vaccinia virus the reduction is likely
due to a non-speciﬁc effect of viral disruption of host transcripts
occurring later in infection.
The one other poxvirus that is predicted to have an MHC-I
homolog is Molluscum contagiosum, a virus in a genus of its own
that causes self-limiting skin lesions that can last formonths.While
the homology of the putativeMHC-I homologMC080R toMHC-
I is quite weak, the protein can associate with β2 microglobulin
(Senkevich and Moss, 1998). MC080R has a predicted transmem-
brane domain and therefore is unlikely to be an antagonist of
NKG2D. In fact, the protein remains in the ER even with vaccinia
virus infection, in a manner reminiscent of UL18 from HCMV
(Senkevich and Moss, 1998). Unfortunately, challenges in propa-
gating the virus in tissue culture and the lack of an animal model
means there is no information regarding the effect of Molluscum
contagiosum on MHC-I expression or immune cell recognition
of infected cells. None-the-less, it would be interesting to test
if the MHC-I-like protein from Molluscum contagiosum binds
to any of the MHC-I-speciﬁc inhibitory or activating receptors
from human. If Molluscum contagiosum could inhibit NK cells, it
might ﬁt with how the lesions remain virtually inﬂammation free
for months.
Finally, we examined the possibility that the NKRP-1 recep-
tor system might be important in the response to infection by
poxviruses similar to its role in rat CMV infection (Voigt et al.,
2007). We found that Clr-b, the ligand of NKRP-1B, is reduced in
cells infected by either ectromelia virus or vaccinia virus and that
this does limit inhibition mediated through Clr-b (Williams et al.,
2012). However, we also observed that when infected these mouse
cells were relatively refractory to lysis by IL-2 activated mouse
NK cells from CD-1 mice, effector cells that uniformly express
NKRP-1B. The reasons for the relatively low lysis of the target cells
might be due to other speciﬁc or non-speciﬁc immune-evasion
mechanisms that prevent stimulation [e.g., viral hemagglutinin,
decreases in intercellular adhesion molecule (ICAM), evasion of
apoptosis cascade, etc.]. Further studies are required to determine
if modulation of this set of ligands occurs in other species with
the relevant poxviruses and how CD-1 mice deal with ectromelia
virus infection. It may also be interesting to consider how other
members of this family may play a role in NK cell recognition
of pox infection, such as lectin-like transcript-1 (LLT1), which
is the human homolog of Clr-b. For humans, the related recep-
tor NKp65 might be of relevance too given the ligand of NKp65
is keratinocyte-associated c-type lectin, a molecule that is selec-
tively expressed by keratinocytes and is perhaps able to stimulate
NK cells that are making their way to the epidermis (Spreu et al.,
2010). This could bemost pertinent for infection withMolluscum
contagiosum or dermal infection with vaccinia virus.
THE GENETIC BASIS OF ECTROMELIA VIRUS RESISTANCE
Many years ago it was noticed that most inbred strains of mice
are highly susceptible to ectromelia virus including A/J, DBA/2J,
BALB/cByJ,A.By/SnJ, andC3H/HeJ,while resistant strains include
129, C57BL/6, AKR/J, with C57LJ exhibiting intermediate resis-
tance (Wallace andBuller, 1985; Fang et al., 2008). Classical genetic
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studies also established that one of four loci that confer resistance
to ectromelia virus in C57BL/6 maps to the NKC (Delano and
Brownstein, 1995). Of the several receptor gene families that are
encoded within the mouse NKC that might inﬂuence the response
to ectromelia virus, CD94 appears to be an important locus
mutated in CBA/2J mice. Sigal and colleagues (Fang et al., 2011)
noted that the susceptible strain DBA/J2 mice lack CD94 (Vance
et al., 2002), while DBA/2, C57BLB/6 and 129 mice have CD94,
suggesting CD94 could be involved in the response to ectromelia
virus. To test if CD94 could be the resistance gene in CD57BL/6
mice missing in DBA/2J mice, Fang et al. (2011) infected C57BL/6
mice targeted for deletion of CD94 with ectromelia virus. These
mice do not have any noticeable defect in NK cell development
or function (Orr et al., 2010), but they are highly susceptible
to ectromelia infection and the phenotype is rescued by trans-
genic CD94 (Fang et al., 2011). CD94 forms complexes with the
chains NKG2A, NKG2C, or NKG2E. The NKG2A chain con-
fers an inhibitory signal due to immunoreceptor tyrosine-based
inhibitory motifs (ITIMs) in the cytoplasmic domain, whereas
NKG2C and NKG2E couple to DAP12 and deliver stimulatory
signals. The ligand of all of these receptors is Qa-1, the mouse
equivalent of HLA-E in humans. Qa-1 expression is maintained
through production of the signal sequences from classical MHC-I
protein and is typically thought of as required to protect cells from
NKcell lysis through engagingCD94/NKG2A,an inhibitory recep-
tor expressed by a large fraction of NK cells. However, staining for
Qa-1 was actually increased on L cells infected with ectromelia in
vitro 4 h post-infection (Fang et al., 2011). While the increase in
Qa-1 is likely what leads to stimulation through CD94/NKG2E,
why only NKG2E and not NKG2C functions in this capacity
remains to be determined. In addition, how Qa-1 is increased
and the nature of peptide loaded into the Qa-1 molecules was
not examined. The regulation of the NKG2 chains may also be
important in the response. While the inhibitory chain NKG2A
is expressed in normal mice in a large fraction of cells, the acti-
vating chains NKG2C and NKG2E may need to be induced by
cytokines in response to infection. The paucity of antibodies spe-
ciﬁc for NKG2Emakes it difﬁcult to assess properly its expression.
It should also be noted that while the CD94/NKG2E complex is
necessary for resistance to ectromelia on a C57BL/6 background,
it is not sufﬁcient to confer resistance on a DBA/2 background
as CBA/2NCr mice express CD94 (Brownstein et al., 1991; Vance
et al., 2002) and yet are highly susceptible to ectromelia. There-
fore, there must be other defects in CBA-derived lines that confer
susceptibility to ectromelia. It could be due to another problem
within the NKC such as NKG2E, the ligand Qa-1, or a defect in
other key pathways such as interferon. Also coincidentally, several
of the susceptible strains such as BALB/c have relatively low levels
of messenger RNA for three members of the NKRP1 gene family
(Giorda et al., 1992).
The role MHC-I in resistance to ectromelia virus (and there-
fore ultimately Ly49s)was initially thought to be negligible because
similar resistance to the virus was found when the H-2b MHC-I
genotype of resistant C57BL/6 was compared with H-2d genotype
from the susceptible DBA/2J and BALB/c strains on a B10 back-
ground (O’Neill et al., 1983). Subsequent crosses of DBA2/J and
C57BL/6 did reveal one of the four resistance markers, rmp3, to
be on chromosome 17 near the H-2 locus but not H-2Db itself
(Brownstein et al., 1992). It is quite possible that the rmp3 locus
is Qa-1 itself, although deletion of Qa-1 in CD57BL/6 does not
completely recapitulate the loss of CD94 and produces an inter-
mediate phenotype (Fang et al., 2011). On the other hand, for
C57BL/6 mice, the presence of Ly49H is somewhat detrimen-
tal to the response to ectromelia virus (Fodil-Cornu et al., 2008).
Ly49h−/− mice on aC57BL/6 background control viral replication
in the spleen by about two orders of magnitude better than wild-
type mice, particularly when infected at a low dose in the footpad,
which is the method by which a role for NK cells is most evident.
This somewhat puzzling observation suggests that Ly49H inﬂu-
ences either undetermined shifts in the NK receptor repertoire,
or competes for signaling by the receptors required for activating
NK cells in the context of ectromelia virus infection. It is possi-
ble the effect of Ly49H is through limiting DAP12 availability for
CD94/NKG2E.
QUESTIONS REMAINING
In the last fewyears,many studies have emerged explaining someof
the fundamental processes in how NK cells respond to poxviruses
and the receptors involved (see Figures 1 and 2). Highlighting
these is the elucidation of CD94/NKG2E as a key stimulatory
receptor required for resistance to ectromelia virus likely in con-
junction with NKG2D. Although CD94/NKG2A appears to be
necessary for protection from ectromelia virus in C57BL/6 mice,
other susceptible strains such as BALB/c express CD94 but are
highly susceptible to ectromelia indicating CD94/NKG2E is neces-
sary but not sufﬁcient for resistance. Several interesting questions
remain in regard to CD94/NKG2E activation such as what causes
the increase in Qa-1, if the peptide loaded into Qa-1 plays a
role, and if this receptor plays a role in any other species. Given
the homology with NKG2A, it may also be interesting to better
understand the mechanism of vaccinia virus A40R that manifests
its phenotype only upon dermal infection. Also, since C57BL/6
mice require TLR2 to respond to vaccinia virus, but CD57BL/6
TLR2−/− mice survive ectromelia infection (Sutherland et al.,
2011), the ability of vaccinia virus to stimulate TLR2 on NK cells
may be a fundamental difference in how mice deal with these
two viruses. Other interesting questions include determining how
various mouse strains differ in their response to cowpox or mon-
keypox and the importance of CPXV203 to pathogenesis, and if
mouse NKp46 is involved in the response to poxviruses in vivo.
It will in the future be interesting to determine if and how these
ancient viruses have left an imprint on the NK receptor reper-
toire of mice or other species, particularly in humans. Although
difﬁcult to ever tackle experimentally, variola virus might well
have shaped the human NK receptor repertoire given the toll it
took on various populations. Molluscum contagiosum presents
the opposite extreme in humans as this virus has likely co-evolved
with its host to become its current mild and quite persistent form.
Genome-wide analyses of the immune response to vaccinia virus
in humans have not yet yielded any obvious NK cell-associated
proteins. However, one SNP associated with IFN-γ production
in T cells in African-Americans (rs1549932), is coincidentally
located at 19q13.4, near the region that also encodes the leukocyte
receptor complex containing the KIRs (Kennedy et al., 2012a,b).
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FIGURE 2 | Mouse NK cell recognition of ectromelia virus-infected cells.The activating and inhibitory mouse receptors and ligands are shown for
ectromelia virus infection. The effect of infection on the ligands is indicated with an arrow for molecules that increase and a line to proteins that are reduced.
A study just published demonstrates that when used as oncolytic
virus, poxviruses can prevent post-surgical metastasis by increas-
ing NK activity (Tai et al., 2012). Together, the recent advances
suggest better understanding of how NK cells are involved in
the immune response to poxviruses in humans is not simply
for the sake of curiosity, but should assist rationale design of
poxvirus-based vaccine vectors or immune-therapies to elicit the
NK response.
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